Abstract
Translating the results of research into clinical practice in critically ill patients is a challenging endeavor and often a slow, complex process. The literature is replete with evidence-based guidelines for the prevention and treatment of infections in critically ill patients aimed to standardize care, reduce costs, and improve patient outcomes [1–4]. Despite the widespread publicity of such documents, non-adherence to guidelines is readily apparent and directly impacts patient morbidity and mortality [5–7]. Explanations for the lack of guideline adherence include disagreement with interpretation of clinical trials, limited evidence in support of specific pharmacologic or non-pharmacologic treatment strategies, and simply the hesitancy to change practices at the beside.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Dellinger RP, Carlet JM, Masur H, et al. (2004) Surviving sepsis campaign guidelines form anagement of severe sepsis and septic shock. Crit Care Med 32(3):858–73
Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171(4):388–416
Mandell LA, Bartlett JG, Dowell SF, File TM, Jr, Musher DM, Whitney C (2003) Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 37(11):1405–33
Kollef MH (1999) The prevention of ventilator-associated pneumonia. N Engl J Med 340(8):627–34
Bodi M, Rodriguez A, Sole-Violan J, et al. (2005) Antibiotic prescription for community-acquired pneumonia in the intensive care unit: impact of adherence to Infectious Diseases Society of America guidelines on survival. Clin Infect Dis 41(12):1709–16
Menendez R, Torres A, Zalacain R, et al. (2005) Guidelines for the treatment of community-acquired pneumonia: predictors of adherence and outcome. Am J Respir Crit Care Med 172(6):757–62
Rello J, Lorente C, Bodi M, Diaz E, Ricart M, Kollef MH (2002) Why do physicians not follow evidence-based guidelines for preventing ventilator-associated pneumonia? A survey based on the opinions of an international panel of intensivists. Chest 122(2):656–61
Ely EW, Baker AM, Dunagan DP, et al. (1996) Effect on the duration of mechanical ventilation of identifying patients capable of breathing spontaneously. N Engl J Med 335(25):1864–9
Kollef MH, Shapiro SD, Silver P, et al. (1997) A randomized, controlled trial of protocol-directed versus physician-directed weaning from mechanical ventilation. Crit Care Med 25(4):567–74
Horst HM, Mouro D, Hall-Jenssens RA, Pamukov N (1998) Decrease in ventilation time with a standardized weaning process. Arch Surg 133(5):483–8; discussion 8–9
Brook AD, Ahrens TS, Schaiff R, et al. (1999) Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 27(12):2609–15
Kress JP, Pohlman AS, O’Connor MF, Hall JB (2000) Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation. N Engl JMed 342(20):1471–7
Van den Berghe G, Wouters P, Weekers F, et al. (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345(19):1359–67
Kollef MH, Ward S (1998) The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia. Chest 113(2):412–20
Luna CM, Vujacich P, Niederman MS, et al. (1997) Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 111(3):676–85
Alvarez-Lerma F (1996) Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group. Intensive Care Med 22(5):387–94
Iregui M, Ward S, Sherman G, Fraser VJ, Kollef MH (2002) Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia. Chest 122(1):262–8
Babcock HM, Zack JE, Garrison T, Trovillion E, Kollef MH, Fraser VJ (2003) Ventilator-associated pneumonia in a multi-hospital system: differences in microbiology by location. Infect Control Hosp Epidemiol 24(11):853–8
Namias N, Samiian L, Nino D, et al. (2000) Incidence and susceptibility of pathogenic bacteria vary between intensive care units within a single hospital: implications for empiric antibiotic strategies. J Trauma 49(4):638–45; discussion 45–6
Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH (2001) Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 29(6):1109–15
Wood GC, Mueller EW, Croce MA, Boucher BA, Hanes SD, Fabian TC (2005) Evaluation of a clinical pathway for ventilator-associated pneumonia: changes in bacterial flora and the adequacy of empiric antibiotics over a three-year period. Surg Infect 6(2):203–13
Rello J, Vidaur L, Sandiumenge A, et al. (2004) De-escalation therapy in ventilator-associated pneumonia. Crit Care Med 32(11):2183–90
Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL (2000) Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 162(2):505–11
Micek ST, Ward S, Fraser VJ, Kollef MH (2004) A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 125(5):1791–9
Hotchkiss RS, Karl IE (2003) The pathophysiology and treatment of sepsis. N Engl J Med 348(2):138–50
Annane D, Bellissant E, Cavaillon JM (2005) Septic shock. Lancet 365(9453):63–78
Rivers E, Nguyen B, Havstad S, et al. (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345(19):1368–77
Annane D, Sebille V, Charpentier C, et al. (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288(7):862–71
Bernard GR, Vincent J-L, Laterre P-F, et al. (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344(10):699–709
Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D (2003) Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med 115(7):529–35
Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C (2003) Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Crit Care Med 31(12):2742–51
Micek ST, Isakow W, Shannon W, Kollef MH (2005) Predictors of hospital mortality for patients with severe sepsis treated with Drotrecogin alfa (activated). Pharmacotherapy 25(1):26–34
Vyas D, Javadi P, DiPasco PJ, Buchman TG, Hotchkiss RS, Coopersmith CM (2005) Early antibiotic administration but not antibody therapy directed against IL-6 improves survival in septic mice predicted to die on basis of high IL-6 levels. Am J Physiol Regul Integr Comp Physiol 289(4):R1048–53
Trzeciak S, Dellinger RP, Abate NL, et al. (2006) Translating research to clinical practice: a 1-year experience with implementing early goal-directed therapy for septic shock in the emergency department. Chest 129(2):225–32
Shapiro NI, Howell M, Talmor D (2005) A blueprint for a sepsis protocol. Acad Emerg Med 12(4):352–9
Micek ST, Roubinian N, Heuring T, et al. (2006) A before-after study of a standardized hospital order set for the management of septic shock. Crit Care Med (in press)
Shapiro NI, Howell MD, Talmor D, et al. (2006) Implementation and outcomes of the Multiple Urgent Sepsis Therapies (MUST) protocol. Crit Care Med 34(4):1025–32
Kortgen A, Niederprum P, Bauer M (2006) Implementation of an evidence-based “standard operating procedure” and outcome in septic shock. Crit Care Med 34(4):943–9
Gao F, Melody T, Daniels DF, Giles S, Fox S (2005) The impact of compliance with 6-hour and 24-hour sepsis bundles on hospital mortality in patients with severe sepsis: a prospective observational study. Crit Care 9(6):R764–70
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Micek, S.T., Kollef, M.H. (2007). Using Protocols To Improve the Outcomes of Critically Ill Patients with Infection: Focus on Ventilator-Associated Pneumonia and Severe Sepsis. In: Rello, J., Kollef, M., Díaz, E., Rodríguez, A. (eds) Infectious Diseases in Critical Care. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-34406-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-540-34406-3_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-34405-6
Online ISBN: 978-3-540-34406-3
eBook Packages: MedicineMedicine (R0)